...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: No mention of efficacy again...
1
Mar 27, 2019 01:04PM
6
Mar 29, 2019 01:05PM

One thing I forgot in my last post. From the articles on Vascular Dementia that BDAZ gave us links to earlier in the week there is not a single medication at this time to deal with this problem. With zero competition that could be a lucrative market. Of course we first have to pass BoM and get good numbers on that secondary study for this to be worth anything. Waiting for the trial to complete is a nail biter at this time.

tada

 

4
Mar 29, 2019 07:25PM
2
Mar 29, 2019 07:59PM
4
bfw
Mar 29, 2019 09:04PM
2
Mar 29, 2019 09:07PM
2
Mar 29, 2019 09:27PM
Share
New Message
Please login to post a reply